PRS Hospital's screening mammography service is designed to detect breast cancer at an early stage, enabling earlier treatment and potentially improving outcomes by addressing the disease before it spreads. Research, including randomized clinical trials, has shown that regular screening mammography can significantly reduce breast cancer mortality, particularly in women aged 40 to 74 who are at average risk for the disease. This early detection plays a crucial role in improving survival rates and treatment effectiveness.
PRS Hospital now offers the Metaltronica Lilyum 2023, a state-of-the-art, painless digital mammogram for advanced breast imaging. This new technology enhances patient comfort while providing high-quality images for early detection and diagnosis.